» Articles » PMID: 29899849

Lymph Microvascularization As a Prognostic Indicator in Neuroblastoma

Overview
Journal Oncotarget
Specialty Oncology
Date 2018 Jun 15
PMID 29899849
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Neuroblastoma is the most common extra-cranial solid pediatric cancer and causes approximately 15% of all childhood deaths from cancer. Although lymphatic vasculature is a prerequisite for the maintenance of tissue fluid balance and immunity in the body, little is known about the relationship between lymphatic vascularization and prognosis in neuroblastoma. We used our previously-published custom-designed tool to close open-outline vessels and measure the density, size and shape of all lymphatic vessels and microvascular segments in 332 primary neuroblastoma contained in tissue microarrays. The results were correlated with clinical and biological features of known prognostic value and with risk of progression to establish histological lymphatic vascular patterns associated with unfavorable histology. A high proportion of irregular intermediate lymphatic capillaries and irregular small collector vessels were present in tumors from patients with metastatic stage, undifferentiating neuroblasts and/or classified in the high risk. In addition, a higher lymphatic microvascularization density was found to be predictive of overall survival. Our findings show the crucial role of lymphatic vascularization in metastatic development and maintenance of tumor tissue homeostasis. These patterns may therefore help to indicate more accurate pre-treatment risk stratification and could provide candidate targets for novel therapies.

Citing Articles

Lymphatic Vessels in Chronic Rhinosinusitis.

Pesold V, Wendler O, Grohn F, Mueller S J Inflamm Res. 2024; 17:865-880.

PMID: 38348276 PMC: 10860572. DOI: 10.2147/JIR.S436450.


Vitronectin-based hydrogels recapitulate neuroblastoma growth conditions.

Monferrer E, Dobre O, Trujillo S, Oliva M, Trubert-Paneli A, Acevedo-Leon D Front Cell Dev Biol. 2022; 10:988699.

PMID: 36425532 PMC: 9679952. DOI: 10.3389/fcell.2022.988699.


Intra-Tumour Genetic Heterogeneity and Prognosis in High-Risk Neuroblastoma.

Lopez-Carrasco A, Berbegall A, Martin-Vano S, Blanquer-Maceiras M, Castel V, Navarro S Cancers (Basel). 2021; 13(20).

PMID: 34680323 PMC: 8534138. DOI: 10.3390/cancers13205173.


Differentiating Neuroblastoma: A Systematic Review of the Retinoic Acid, Its Derivatives, and Synergistic Interactions.

Bayeva N, Coll E, Piskareva O J Pers Med. 2021; 11(3).

PMID: 33809565 PMC: 7999600. DOI: 10.3390/jpm11030211.


Digital Image Analysis Applied to Tumor Cell Proliferation, Aggressiveness, and Migration-Related Protein Synthesis in Neuroblastoma 3D Models.

Monferrer E, Sanegre S, Martin-Vano S, Garcia-Lizarribar A, Burgos-Panadero R, Lopez-Carrasco A Int J Mol Sci. 2020; 21(22).

PMID: 33212997 PMC: 7698558. DOI: 10.3390/ijms21228676.


References
1.
Garcia-Caballero M, Paupert J, Blacher S, Van de Velde M, Quesada A, Medina M . Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases. J Hematol Oncol. 2017; 10(1):122. PMC: 5477162. DOI: 10.1186/s13045-017-0484-1. View

2.
Ozer E, Altungoz O, Unlu M, Aygun N, Tumer S, Olgun N . Association of MYCN amplification and 1p deletion in neuroblastomas with high tumor vascularity. Appl Immunohistochem Mol Morphol. 2007; 15(2):181-6. DOI: 10.1097/01.pai.0000210418.38246.58. View

3.
Kashima K, Watanabe M, Satoh Y, Hata J, Ishii N, Aoki Y . Inhibition of lymphatic metastasis in neuroblastoma by a novel neutralizing antibody to vascular endothelial growth factor-D. Cancer Sci. 2012; 103(12):2144-52. PMC: 7659268. DOI: 10.1111/cas.12010. View

4.
Sabarinath B, Sriram G, Saraswathi T, Sivapathasundharam B . Immunohistochemical evaluation of mast cells and vascular endothelial proliferation in oral submucous fibrosis. Indian J Dent Res. 2011; 22(1):116-21. DOI: 10.4103/0970-9290.80009. View

5.
Ullah E, Nagi A, Lail R . Angiogenesis and mast cell density in invasive pulmonary adenocarcinoma. J Cancer Res Ther. 2013; 8(4):537-41. DOI: 10.4103/0973-1482.106530. View